Keller Julia, Camaré Caroline, Bernis Corinne, Astello-García Marizel, de la Rosa Ana-Paulina Barba, Rossignol Michel, del Socorro Santos Díaz María, Salvayre Robert, Negre-Salvayre Anne, Guéraud Françoise
INRA Toxalim, Toulouse, France.
J Physiol Biochem. 2015 Sep;71(3):577-87. doi: 10.1007/s13105-015-0408-x. Epub 2015 Apr 4.
Opuntia species have been used for thousands of years as a folk medicine in the treatment of diseases. However, the components and protective mechanisms are still unclear. We make the hypothesis that Opuntia species may protect the development of oxidative stress-associated diseases, such as atherosclerosis or colon cancer, via their antioxidant properties. We investigated the protective effect of Opuntia cladode powder against the oxidation of low-density lipoprotein (LDL) evoked by vascular endothelial cells, an important risk factor for atherosclerosis development, and the toxicity of 4-hydroxynonenal (a major lipid peroxidation product) on normal (Apc +/+) and preneoplastic (Apc min/+) immortalized epithelial colon cells. Various Opuntia species classified according to their degree of domestication, from the wildest (Opuntia streptacantha, Opuntia hyptiacantha, Opuntia megacantha), medium (Opuntia albicarpa), to the most domesticated (Opuntia ficus-indica) were tested. Cladode powders prepared from these Opuntia species significantly inhibited LDL oxidation induced by incubation with murine endothelial cells and the subsequent foam cell formation of RAW 264.7 murine macrophages and cytotoxicity on murine endothelial cells. Moreover, Opuntia cladode powder blocked the promotion of colon cancer development on an in vitro model of colonocytes. It may be noted that the phenolic acid and flavonoids content, the antioxidant capacity, and the protective effect were relatively similar in all the cladode powders from wild (O. streptacantha) and domesticated Opuntia. Altogether, these data confirm the therapeutic potential of Opuntia cladodes in diseases associated with oxidative stress.
仙人掌属植物作为民间药物用于治疗疾病已有数千年历史。然而,其成分和保护机制仍不清楚。我们提出假设,仙人掌属植物可能通过其抗氧化特性来保护与氧化应激相关疾病的发展,如动脉粥样硬化或结肠癌。我们研究了仙人掌茎粉对血管内皮细胞诱导的低密度脂蛋白(LDL)氧化的保护作用,血管内皮细胞是动脉粥样硬化发展的一个重要危险因素,以及4-羟基壬烯醛(一种主要的脂质过氧化产物)对正常(Apc +/+)和癌前(Apc min/+)永生化结肠上皮细胞的毒性。测试了根据驯化程度分类的各种仙人掌属植物,从最野生的(刺梨仙人掌、少刺仙人掌、巨刺仙人掌)、中等驯化程度的(白肉仙人掌)到最驯化的(梨果仙人掌)。由这些仙人掌属植物制备的茎粉显著抑制了与小鼠内皮细胞孵育诱导的LDL氧化以及随后RAW 264.7小鼠巨噬细胞的泡沫细胞形成和对小鼠内皮细胞的细胞毒性。此外,仙人掌茎粉在结肠细胞的体外模型中阻断了结肠癌的发展。值得注意的是,野生(刺梨仙人掌)和驯化仙人掌的所有茎粉中的酚酸和黄酮含量、抗氧化能力和保护作用相对相似。总之,这些数据证实了仙人掌茎在与氧化应激相关疾病中的治疗潜力。